CCR1 and neoplasm: In gastric cancer models, Chen et al. revealed that CCL7–CCR1 signaling activates the ERK/ELK1 pathway, drives SOX18 expression, and upregulates CCL7 to establish a positive feedback loop that enhances tumor invasiveness [18].